01:57:14 EDT Tue 16 Jul 2024
Enter Symbol
or Name
USA
CA



T:TH - THERATECHNOLOGIES INC. - http://www.theratech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TH - T  0.32.08·2.120.12.12+0.157.637.5751231.98  2.15  1.984.60  1.2215:59:59Jul 1015 min RT 2¢
TSX - T0.32.08·2.120.12.11+0.147.119.739601.98  2.15  1.984.60  1.2215:59:2915 min
NEO ATS - U 2.12+0.157.63.37132.00  2.13  2.0015:55:2215 min
Alpha - A 2.12+0.157.65.51172.00  2.12  2.0015:59:5915 min
Pure - P 2.08+0.115.60.5172.03  2.08  2.0314:12:5115 min
Chi-X - X 2.11+0.147.18.217272.00  2.13  2.0015:59:2815 min
CXD - D 1.970.021    Jul 1215 min
TriAct - M 1.970.418    Sep 11/2015 min

Recent Trades - Last 10 of 123
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59A2.120.1510079 CIBC79 CIBCK
15:59:29A2.120.153,6001 Anonymous79 CIBCK
15:59:29T2.110.1430079 CIBC7 TD SecK
15:59:29T2.110.1410079 CIBC7 TD SecK
15:59:29T2.110.1410079 CIBC79 CIBCK
15:59:29P2.110.146079 CIBC14 Virtu ITGE
15:59:28X2.110.1410080 National Bank1 AnonymousK
15:55:22X2.090.1220079 CIBC79 CIBCK
15:55:22X2.090.1220079 CIBC79 CIBCK
15:55:22T2.110.145080 National Bank1 Anonymous

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-07-10 08:53C:TH2.10SEDAR Interim MD & ASEDAR Interim MD & A
2024-07-10 08:53C:TH2.10SEDAR Interim MD & ASEDAR Interim MD & A
2024-07-10 08:47C:TH2.10SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-07-10 07:30C:TH2.10News ReleaseTheratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024
2024-06-26 11:33C:TH1.78News ReleaseTheratechnologies to release Q2 2024 results July 10
2024-05-23 17:07C:TH1.71News ReleaseTheratechnologies' TH1902 phase 1 data show efficacy
2024-05-09 16:48C:TH1.71News ReleaseTheratechnologies holders elect 8 directors at meeting
2024-04-15 16:39C:TH1.80News ReleaseTheratechnologies mails proxy circular for May 9 AGM
2024-04-10 11:45C:TH2.09News ReleaseTheratechnologies loses $4.48-million (U.S.) in Q1
2024-04-10 07:54C:TH2.09SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-04-10 07:54C:TH2.09SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-10 07:54C:TH2.09SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-08 16:43C:TH1.93News ReleaseTheratechnologies presents preclinical data on SORT1+
2024-04-05 11:28C:TH2.06News ReleaseTheratechnologies appoints Tea as director
2024-04-03 11:00C:TH2.16News ReleaseTheratechnologies to release Q1 2024 results April 10
2024-03-22 10:56C:TH1.70News ReleaseTheratechnologies to cut preclinical cancer research
2024-03-21 20:06C:TH1.70News ReleaseTheratechnologies appoints Zwick as director
2024-03-21 10:52C:TH1.65News ReleaseTheratechnologies increases dose level in phase 1 trial
2024-02-29 16:38C:TH2.01News ReleaseTheratechnologies director Trudeau resigns
2024-02-27 08:30C:TH2.20News ReleaseTheratechnologies gets refusal-to-file letter from FDA